Position in ARGX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$403,828
-$41,875 QoQ
Shares Held
553
+4.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $172,911,965 across 172 Biotechnology names. ARGX ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,977,404 | $160,329,155 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,522 | $2,465,793 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $1,869,631 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,107 | $855,312 | |
| 5 | INCY |
Incyte Corp
|
4,919 | $462,976 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
14,020 | $456,210 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,688 | $436,044 | |
| 8 | ARGX |
Argenx SE
This page
|
553 | $403,828 |
All Filings in ARGX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $403,828 | 553 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $445,703 | 530 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $438,110 | 594 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $337,897 | 613 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $371,099 | 627 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $415,740 | 676 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $325,248 | 600 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $233,511 | 543 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $210,640 | 535 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $149,128 | 392 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $231,557 | 471 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $175,768 | 451 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $163,562 | 439 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $162,896 | 430 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $138,748 | 393 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $127,682 | 337 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $93,331 | 296 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $134,122 | 383 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $40,468 | 134 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $16,558 | 55 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $17,349 | 63 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $7,058 | 24 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,100 | 8 | Shares | Sole | 2020-10-27 | |
| 2020-03-31 | $8,035 | 61 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||